Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heckman, W. R.
Right arrow Articles by Cosentino, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heckman, W. R.
Right arrow Articles by Cosentino, M. J.

Journal of Andrology, Vol 13, Issue 3 191-198, Copyright © 1992 by The American Society of Andrology

JOURNAL ARTICLE

The effect of ketoconazole on endocrine and reproductive parameters in male mice and rats

W. R. Heckman, B. R. Kane, R. E. Pakyz and M. J. Cosentino
Department of Biology, Millersville University, Pennsylvania 17551.

Ketoconazole has been shown to reduce steroidogenesis by inhibiting the cytochrome P-450 enzymes in these pathways. This finding, along with the observation that the compound reduces sperm motility, led us to study the effectiveness of ketoconazole as a male contraceptive agent administered in acute and chronic studies of both rats and mice. Four hours after a single administration, male rats showed significant reductions in both serum testosterone and corticosterone levels that completely recovered (testosterone) or nearly recovered (corticosterone) 24 hours after administration. Chronic administration of ketoconazole to male rats and mice resulted in steroid levels comparable with those of control animals. Epididymal sperm motility was only slightly reduced in male mice 4 hours after administration of the drug. No effect on sperm motility was noted after chronic administration in either species studied. In vitro exposure of epididymal sperm to ketoconazole resulted in a significant reduction of sperm motility. Breeding trials after ketoconazole administration resulted in normal fertility and fecundity even at the highest dosage studied. The lack of correlation between steroid levels and sperm immobilization, along with rapid in vivo and in vitro effects on sperm motility, suggests that the reduction in sperm motility is not related to a decrease in steroid levels. From these data, the authors conclude that ketoconazole is probably not a viable approach to the development of a male contraceptive.


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
Z. Sarnyai, Y. Shaham, and S. C. Heinrichs
The Role of Corticotropin-Releasing Factor in Drug Addiction
Pharmacol. Rev., June 1, 2001; 53(2): 209 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
V. S. Wilson and G. A. LeBlanc
The Contribution of Hepatic Inactivation of Testosterone to the Lowering of Serum Testosterone Levels by Ketoconazole
Toxicol. Sci., March 1, 2000; 54(1): 128 - 137.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The American Society of Andrology.